MedPath

National Heart, Lung, and Blood Institute

National Heart, Lung, and Blood Institute logo
🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Emory Angioplasty Versus Surgery Trial (EAST)

Phase 3
Completed
Conditions
Heart Diseases
Coronary Disease
Myocardial Ischemia
Cardiovascular Diseases
First Posted Date
1999-10-28
Last Posted Date
2016-02-18
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000465

Estrogen and Graft Atherosclerosis Research Trial (EAGER)

Phase 3
Completed
Conditions
Coronary Arteriosclerosis
Myocardial Ischemia
Postmenopause
Heart Diseases
Cardiovascular Diseases
Coronary Disease
First Posted Date
1999-10-28
Last Posted Date
2016-02-18
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000605

Estrogen Replacement and Atherosclerosis (ERA) in Older Women

Phase 3
Completed
Conditions
Myocardial Ischemia
Coronary Arteriosclerosis
Cardiovascular Diseases
Coronary Disease
Heart Diseases
Postmenopause
First Posted Date
1999-10-28
Last Posted Date
2016-03-16
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000549

Women's Estrogen/Progestin Lipid Lowering Hormone Atherosclerosis Regression Trial (WELL-HART)

Phase 3
Completed
Conditions
Postmenopause
Cardiovascular Diseases
Coronary Disease
Heart Diseases
Myocardial Ischemia
First Posted Date
1999-10-28
Last Posted Date
2016-07-12
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000559

Hypertension Detection and Follow-up Program (HDFP)

Phase 3
Completed
Conditions
Heart Diseases
Cardiovascular Diseases
Hypertension
Vascular Diseases
First Posted Date
1999-10-28
Last Posted Date
2016-07-12
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000485

Nocturnal Oxygen Therapy

Phase 3
Completed
Conditions
Lung Diseases
Lung Diseases, Obstructive
Chronic Obstructive Pulmonary Disease
First Posted Date
1999-10-28
Last Posted Date
2005-06-24
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000564

PREMIER: Lifestyle Interventions for Blood Pressure Control

Phase 3
Completed
Conditions
Hypertension
Heart Diseases
First Posted Date
1999-10-28
Last Posted Date
2016-02-18
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000616

Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED)

Phase 3
Completed
Conditions
Lung Diseases
Pulmonary Embolism
First Posted Date
1999-10-28
Last Posted Date
2016-04-15
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000566

Multicenter Study of Hydroxyurea in Patients With Sickle Cell Anemia (MSH)

Phase 3
Completed
Conditions
Hemoglobinopathies
Hematologic Diseases
Anemia, Sickle Cell
First Posted Date
1999-10-28
Last Posted Date
2016-04-14
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000586

Antiarrhythmics Versus Implantable Defibrillators (AVID)

Phase 3
Completed
Conditions
Death, Sudden, Cardiac
Cardiovascular Diseases
Heart Diseases
Ventricular Fibrillation
Arrhythmia
Tachycardia, Ventricular
First Posted Date
1999-10-28
Last Posted Date
2016-04-14
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000531
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy